{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:08Z","timestamp":1791332528105,"version":"4.3.1"},"reference-count":47,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.1210\/jc.2008-1588","type":"journal-article","created":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T03:59:22Z","timestamp":1233115162000},"page":"1137-1144","source":"Crossref","is-referenced-by-count":108,"title":["The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia"],"prefix":"10.1210","volume":"94","author":[{"given":"Kathleen","family":"Mulligan","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hootan","family":"Khatami","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"},{"name":"Department of Basic Sciences, Touro University (J.-M.S.), Vallejo, California 94592"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos K.","family":"Sakkas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"DePaoli","sequence":"additional","affiliation":[{"name":"Amgen Inc. (A.M.D.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viva W.","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco Veterans Affairs Medical Center (G.A.L., C.G.), San Francisco, California 94121"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco Veterans Affairs Medical Center (G.A.L., C.G.), San Francisco, California 94121"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Schambelan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., G.A.L., C.G., M.S.), San Francisco, California 94143"},{"name":"San Francisco General Hospital (K.M., H.K., J.-M.S., G.K.S., V.W.T., M.J.W., M.S.), San Francisco, California 94110"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113383793500_R1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ijo.0801493","article-title":"A-ZIP\/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes","author":"Reitman","year":"2000","journal-title":"Int J Obes Relat Metab Disord 24(Suppl 4):"},{"key":"key\n\t\t\t\t2019041113383793500_R2","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev"},{"key":"key\n\t\t\t\t2019041113383793500_R3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113383793500_R4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin.","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041113383793500_R5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e31816d9ba1","article-title":"The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.","volume":"48","author":"Wohl","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019041113383793500_R6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1043-2760(00)00309-X","article-title":"Lipoatrophy revisited.","volume":"11","author":"Reitman","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"A Serum adiponectin and leptin levels in patients with lipodystrophies.","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113383793500_R9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","article-title":"Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.","volume":"113","author":"Asilmaz","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113383793500_R10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113383793500_R11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u201cBuffalo hump\u201d in men with HIV-1 infection.","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113383793500_R14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-4825(01)00006-3","article-title":"Java-based graphical user interface for MRUI, a software package for quantitation of in vivo\/medical magnetic resonance spectroscopy signals.","volume":"31","author":"Naressi","year":"2001","journal-title":"Comput Biol Med"},{"key":"key\n\t\t\t\t2019041113383793500_R15","first-page":"E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113383793500_R16","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113383793500_R17","first-page":"23","article-title":"In vivo measurement of insulin sensitivity in humans","author":"Matsuda","year":"1997","journal-title":"In: Drasnin B, Rizza R, eds. Clinical research in diabetes and obesity. Vol 1. Methods, assessment, and metabolic regulation. Totowa, NJ: Humana Press, Inc.;"},{"key":"key\n\t\t\t\t2019041113383793500_R18","volume-title":"Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis","author":"Wolfe","year":"1992"},{"key":"key\n\t\t\t\t2019041113383793500_R19","first-page":"E988","article-title":"Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers","volume":"263","author":"Hellerstein","year":"1992","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113383793500_R20","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1074\/jbc.270.24.14452","article-title":"Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads.","volume":"270","author":"Neese","year":"1995","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113383793500_R21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0026-0495(88)90110-2","article-title":"The theoretical bases of indirect calorimetry: a review.","volume":"3","author":"Ferrannini","year":"1988","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113383793500_R22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ajcn\/88.4.1088","article-title":"Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects.","volume":"88","author":"Scherzer","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041113383793500_R23","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus.","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113383793500_R24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113383793500_R25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients.","volume":"35","author":"Kotler","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019041113383793500_R26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/QAI.0b013e31804a7f68","article-title":"Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.","volume":"45","author":"Grunfeld","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019041113383793500_R27","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.","volume":"86","author":"Lo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.","volume":"87","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R29","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV.","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113383793500_R30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113383793500_R31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-143-5-200509060-00009","article-title":"Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.","volume":"143","author":"van Wijk","year":"2005","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113383793500_R32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAD.0b013e328011220e","article-title":"Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist\/hip ratio.","volume":"21","author":"Mulligan","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041113383793500_R33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial.","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113383793500_R34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1468-1293.2007.00488.x","article-title":"A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.","volume":"8","author":"Kohli","year":"2007","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t2019041113383793500_R35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.ijo.0800834","article-title":"Visceral adipose tissue: a critical review of intervention strategies.","volume":"23","author":"Smith","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t2019041113383793500_R36","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1172\/JCI119865","article-title":"Leptin selectively decreases visceral adiposity and enhances insulin action.","volume":"100","author":"Barzilai","year":"1997","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113383793500_R37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113383793500_R38","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.182420899","article-title":"PPAR\u03b1 is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue.","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113383793500_R39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/aid.2005.21.757","article-title":"A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.","volume":"21","author":"Aberg","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2019041113383793500_R40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/01.aids.0000222072.37749.5a","article-title":"Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men-a randomized, placebo-controlled study.","volume":"20","author":"Mallon","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041113383793500_R41","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.aids.0000174458.86121.43","article-title":"Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study.","volume":"19","author":"Calza","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041113383793500_R42","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/135965350601100802","article-title":"Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.","volume":"11","author":"Dube","year":"2006","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t2019041113383793500_R43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAI.0b013e31815bace2","article-title":"Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.","volume":"47","author":"Gerber","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019041113383793500_R44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113383793500_R45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bbrc.2003.11.053","article-title":"Overexpression of leptin in transgenic mice leads to decreased basal lipolysis, PKA activity, and perilipin levels.","volume":"312","author":"Ke","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041113383793500_R46","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00058.2002","article-title":"Metabolic basis of HIV-lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383793500_R47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/4\/1137\/10806571\/jcem1137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:46:47Z","timestamp":1684871207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/4\/1137\/2596235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1588","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}